| Jason Neal Ratliff, CRNA | |
|
2222 Philadelphia Dr, Dayton, OH 45406-1813 | |
| (937) 276-8316 | |
| (937) 567-4163 |
| Full Name | Jason Neal Ratliff |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 13 Years |
| Location | 2222 Philadelphia Dr, Dayton, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093082653 | NPI | - | NPPES |
| 000000749150 | Other | OH | ANTHEM |
| LINKED | Other | OH | TRICARE / NON-NETWORK |
| 0059752 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN330055 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Miami Valley Hospital | Dayton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesiology Services Network Ltd | 8820902794 | 176 |
News Archive
Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say.
Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.
Baby boomers have witnessed many technological innovations, and they expect technology to provide them with solutions to help maintain their independence for as long as possible. They are outfitting their homes with products to help them live healthy lifestyles, manage chronic conditions, remember to take medications and remain connected with their caregivers.
What is perhaps the most wonderous and fascinating creation of nature, the brain, attracting, on one level or another, over centuries, human curiosity, becomes a welcoming territory to be explored from a fresh new perspective of mathematical and cortical synergies in Prof. Yoram Baram's latest publication.
McClatchy asks the central question: "Will it be smooth sailing or a 'train wreck'?" Meanwhile, other news outlets report on issues such as how experts view the possibility of rate shock when consumers shop for coverage from these online marketplaces, as well as other related developments in the District of Columbia, Maryland, Georgia, Ohio and Colorado.
› Verified 9 days ago
| Entity Name | Anesthesiology Services Network Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821076779 PECOS PAC ID: 8820902794 Enrollment ID: O20031114000467 |
News Archive
Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say.
Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.
Baby boomers have witnessed many technological innovations, and they expect technology to provide them with solutions to help maintain their independence for as long as possible. They are outfitting their homes with products to help them live healthy lifestyles, manage chronic conditions, remember to take medications and remain connected with their caregivers.
What is perhaps the most wonderous and fascinating creation of nature, the brain, attracting, on one level or another, over centuries, human curiosity, becomes a welcoming territory to be explored from a fresh new perspective of mathematical and cortical synergies in Prof. Yoram Baram's latest publication.
McClatchy asks the central question: "Will it be smooth sailing or a 'train wreck'?" Meanwhile, other news outlets report on issues such as how experts view the possibility of rate shock when consumers shop for coverage from these online marketplaces, as well as other related developments in the District of Columbia, Maryland, Georgia, Ohio and Colorado.
› Verified 9 days ago
| Entity Name | Gasjobs Of Oh, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235150228 PECOS PAC ID: 3971403130 Enrollment ID: O20040113000149 |
News Archive
Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say.
Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.
Baby boomers have witnessed many technological innovations, and they expect technology to provide them with solutions to help maintain their independence for as long as possible. They are outfitting their homes with products to help them live healthy lifestyles, manage chronic conditions, remember to take medications and remain connected with their caregivers.
What is perhaps the most wonderous and fascinating creation of nature, the brain, attracting, on one level or another, over centuries, human curiosity, becomes a welcoming territory to be explored from a fresh new perspective of mathematical and cortical synergies in Prof. Yoram Baram's latest publication.
McClatchy asks the central question: "Will it be smooth sailing or a 'train wreck'?" Meanwhile, other news outlets report on issues such as how experts view the possibility of rate shock when consumers shop for coverage from these online marketplaces, as well as other related developments in the District of Columbia, Maryland, Georgia, Ohio and Colorado.
› Verified 9 days ago
| Entity Name | Dayton Anesthesia & Pain Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629401898 PECOS PAC ID: 8022245372 Enrollment ID: O20131212001655 |
News Archive
Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say.
Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.
Baby boomers have witnessed many technological innovations, and they expect technology to provide them with solutions to help maintain their independence for as long as possible. They are outfitting their homes with products to help them live healthy lifestyles, manage chronic conditions, remember to take medications and remain connected with their caregivers.
What is perhaps the most wonderous and fascinating creation of nature, the brain, attracting, on one level or another, over centuries, human curiosity, becomes a welcoming territory to be explored from a fresh new perspective of mathematical and cortical synergies in Prof. Yoram Baram's latest publication.
McClatchy asks the central question: "Will it be smooth sailing or a 'train wreck'?" Meanwhile, other news outlets report on issues such as how experts view the possibility of rate shock when consumers shop for coverage from these online marketplaces, as well as other related developments in the District of Columbia, Maryland, Georgia, Ohio and Colorado.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Neal Ratliff, CRNA Po Box 640446, Cincinnati, OH 45264-0446 Ph: (717) 263-5562 | Jason Neal Ratliff, CRNA 2222 Philadelphia Dr, Dayton, OH 45406-1813 Ph: (937) 276-8316 |
News Archive
Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say.
Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.
Baby boomers have witnessed many technological innovations, and they expect technology to provide them with solutions to help maintain their independence for as long as possible. They are outfitting their homes with products to help them live healthy lifestyles, manage chronic conditions, remember to take medications and remain connected with their caregivers.
What is perhaps the most wonderous and fascinating creation of nature, the brain, attracting, on one level or another, over centuries, human curiosity, becomes a welcoming territory to be explored from a fresh new perspective of mathematical and cortical synergies in Prof. Yoram Baram's latest publication.
McClatchy asks the central question: "Will it be smooth sailing or a 'train wreck'?" Meanwhile, other news outlets report on issues such as how experts view the possibility of rate shock when consumers shop for coverage from these online marketplaces, as well as other related developments in the District of Columbia, Maryland, Georgia, Ohio and Colorado.
› Verified 9 days ago
Kathy Waymire, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1 Wyoming St, Dayton, OH 45409 Phone: 800-394-4445 | |
Mr. Robert S Sheeley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Wyoming St, Dayton, OH 45409 Phone: 937-208-4380 Fax: 937-208-3843 | |
Cody Dalton Plapp, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1 Wyoming St, Dayton, OH 45409 Phone: 937-208-6173 Fax: 937-208-3843 | |
Sarah Blesch, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 405 W Grand Ave, Dayton, OH 45405 Phone: 937-723-3200 | |
Mr. Thomas B Hellman, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2222 Philadelphia Dr, Dayton, OH 45406 Phone: 937-278-2612 | |
Trey Overla, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 405 W Grand Ave, Dayton, OH 45405 Phone: 937-723-3200 |